Methyl 4-Pentafluorosulfanylphenyl Sulfoximines

Abstract

A low-cost and high-yielding synthetic route towards methyl 4-pentafluorosulfanylphenyl sulfoximines from the corresponding sulfide has been developed. The intermediate N-cyano sulfoximine was converted into the corresponding N-(1H)-tetrazole, and the NH-sulfoximine was modified by N-arylation and N-alkylation reactions.

Key words

building blocks - pentafluorosulfanyl group - sulfoximine - organofluorine compounds - sulfilimine

• References and Notes


For reviews, see:
• 1a Kirsch P. Modern Fluoroorganic Chemistry . Wiley-VCH; Weinheim: 2004
• 1b Crowley PJ, Mitchell G, Salmon R, Worthington PA. Chimia 2004; 58: 138
• 1c Jeschke P. ChemBioChem 2004; 5: 570
• 1d Pursur S, Moore PR, Swallow S, Gouverneur V. Chem. Soc. Rev. 2008; 37: 320
• 1e Fluorine in Medicinal Chemistry and Chemical Biology. Ojima I. Wiley-Blackwell; Chichester: 2009
• 1f Ojima I. J. Org. Chem. 2013; 78: 6358
• 1g Wang J, Sánchez-Roselló M, Aceña JL, Del Pozo C, Sorochinsky AE, Fustero S, Soloshonok VA, Liu H. Chem. Rev. 2014; 114: 2432
• 2a Sheppard WA. J. Am. Chem. Soc. 1960; 82: 4751
• 2b Welch JT In Fluorine in Pharmaceutical and Medicinal Chemistry . Vol. 6. Gouverneur V, Muellen K. Imperial College Press; London: 2012: 175
• 2c Altomonte S, Zanda M. J. Fluorine Chem. 2012; 143: 57
• 2d Savoie PR, Welch JT. Chem. Rev.
• 3 Sheppard WA. J. Am. Chem. Soc. 1962; 84: 3064
• 4 Sheppard WA. J. Am. Chem. Soc. 1962; 84: 3072
• 5 Hansch C, Muir RM, Fujita T, Maloney PP, Geiger F, Streich M. J. Am. Chem. Soc. 1963; 85: 2817

For recent examples, see:
• 6a Altomonte S, Baillie GL, Ross RA, Riley J, Zanda M. RSC Adv. 2014; 4: 20164
• 6b Chia PW, Brennan SC, Slawin AM. Z, Riccardi D, O’Hagan D. Org. Biomol. Chem. 2012; 10: 7922
• 6c Micheli F, Andreotti D, Braggio S, Checchia A. Bioorg. Med. Chem. Lett. 2010; 20: 4566
• 6d Mo T, Mi X, Milner EE, Dow GS, Wipf P. Tetrahedron Lett. 2010; 51: 5137
• 6e Stump B, Eberle C, Schweizer WB, Kaiser M, Brun R, Krauth-Siegel RL, Lentz D, Diederich F. ChemBioChem 2009; 10: 79
• 6f Wipf P, Mo T, Geib SJ, Caridha D, Dow GS, Gerena L, Roncal N, Milner EE. Org. Biomol. Chem. 2009; 7: 4163
• 6g Lim DS, Choi JS, Pak CS, Welch JT. J. Pestic. Sci. 2007; 32: 255

For examples, see:
• 7a Ye C, Gard GL, Winter RW, Syvret RG, Twamley B, Shreeve JM. Org. Lett. 2007; 9: 3841
• 7b Winner SW, Winter RW, Smith JA, Gard GL, Hannah NA, Rananavare SB, Piknova B, Hall SB. Mendeleev Commun. 2006; 16: 182
• 7c Kirsch P, Hahn A. Eur. J. Org. Chem. 2005; 3095
• 8a Prévost S, Dupré N, Leutzsch M, Wang Q, Wakchaure V, List B. Angew. Chem. Int. Ed. 2014; 53: 8770 ; Angew. Chem. 2014, 126, 8915
• 8b Lee J.-W, List B. J. Am. Chem. Soc. 2012; 134: 18245
• 9a Bowden RD, Greenhall MP, Moillet JS, Thomson J. F2 Chemicals WO9705106, 1997 ; Chem. Abstr. 1997, 126, 199340.
• 9b Umemoto T IM&T Research Inc. WO2010014665 (A1), 2010

For overviews, see:
• 10a Johnson CR. Acc. Chem. Res. 1973; 6: 341
• 10b Reggelin M, Zur C. Synthesis 2000; 1
• 10c Harmata M. Chemtracts 2003; 16: 660
• 10d Okamura H, Bolm C. Chem. Lett. 2004; 33: 482
• 10e Gais H.-J. Heteroat. Chem. 2007; 18: 472
• 10f Worch C, Mayer AC, Bolm C In Organosulfur Chemistry in Asymmetric Synthesis . Torru T, Bolm C. Wiley-VCH; Weinheim: 2008: 209
• 10g Bolm C. Latv. J. Chem. 2012; 49
• 11 For a recent review on sulfoximines in medicinal chemistry, see: Lücking U. Angew. Chem. Int. Ed. 2013; 52: 9399 ; Angew. Chem. 2013, 125, 9570
• 12 For a recent review on sulfoxaflor and sulfoximines used as insecticides, see: Sparks TC, Watson GB, Loso MR, Geng C, Babcock JM, Thomas JD. Pestic. Biochem. Physiol. 2013; 107: 1
• 13a Goldberg FW, Kettle JG, Xiong J, Lin D. Tetrahedron 2014; 70: 6613
• 13b Lücking U, Jautelat R, Krüger M, Brumby T, Lienau P, Schäfer M, Briem H, Schulze J, Hillisch A, Reichel A, Wengner AM, Siemeister G. ChemMedChem 2013; 8: 1067

For overviews on fluorinated sulfoximines, see:
• 14a Bizet V, Kowalczyk R, Bolm C. Chem. Soc. Rev. 2014; 43: 2426
• 14b Shen X, Hu J. Eur. J. Org. Chem. 2014; 4437

For examples of bioactive 4-fluoroaryl sulfoximines, see:
• 15a Shetty SJ, Patel GD, Lohray BB, Chakrabarti G, Chatterjee A, Jain MR, Patel PR. Cadila Healthcare WO2007077574 (A2), 2007
• 15b Kahraman M, Sinishtaj S, Dolan PM, Kensler TW, Peleg S, Saha U, Chuang SS, Bernstein G, Korczak B, Posner GH. J. Med. Chem. 2004; 47: 6854

For other selected contributions including 4-fluoro and 4-trifluoromethylaryl sulfoximines, see:
• 16a Kowalczyk R, Edmunds AJ. F, Hall RG, Bolm C. Org. Lett. 2011; 13: 768
• 16b Barry N, Brondel N, Lawrence SE, Maguire AR. Tetrahedron 2009; 65: 10660
• 16c Terrier F, Magnier E, Kizilian E, Wakselman C, Buncel E. J. Am. Chem. Soc. 2005; 127: 5563
• 16d Reggelin M, Gerlach M, Vogt M. Eur. J. Org. Chem. 1999; 1011
• 17 For the synthesis of 1 starting from 4-nitrophenyl sulfurpentafluoride, see: Beier P, Pastýříková T, Vida N, Iakobson G. Org. Lett. 2011; 13: 1466
• 18 García Mancheño O, Bistri O, Bolm C. Org. Lett. 2007; 9: 3809
• 19 Stoss P, Satzinger G. Tetrahedron Lett. 1973; 267
• 20 Synthesis of NH-Sulfoximine 4 from Sulfide 1; General Procedure: Step 1: To a solution of 1 (1.0 mmol) in MeOH (6 mL), was added NH₂CN (76 mg, 1.8 mmol), t-BuOK (191 mg, 1.7 mmol) and NBS (356 mg, 2.0 mmol). The reaction was stirred at room temperature until the starting material was consumed (reaction monitored by TLC). After removing the solvent under reduced pressure, water (10 mL) was added and the mixture was extracted with CH₂Cl₂ (3 × 20 mL). The combined organic layers were dried over anhydrous magnesium sulfate and the solvents were removed under reduced pressure. Purification by flash column chromatography provided N-cyanosulfilimine 2. Step 2: To a solution of 2 (0.3 mmol) in EtOH (2.7 mL) was added m-CPBA (ca. 70%, 101 mg, 0.45 mmol). The reaction mixture was stirred at room temperature until the starting material was consumed (reaction monitored by TLC). After removing the solvent under reduced pressure, H₂O (5 mL) was added and the mixture was extracted with CH₂Cl₂ (3 × 10 mL). The combined organic layers were dried over anhydrous magnesium sulfate and the solvents were removed under reduced pressure. Purification by flash column chromatography provided N-cyanosulfoximine 3. Step 3: A solution of 3 (0.23 mmol) in 50% aq H₂SO₄ (2.3 mL) was stirred at 110 °C for 2 h. After cooling to room temperature and adjusting the pH to 9 by addition of aq. sat NaHCO₃ and aq. sat NaOH solution, the mixture was extracted with CH₂Cl₂ (3 × 20 mL). The combined organic layers were dried over anhydrous magnesium sulfate and the solvents were removed under reduced pressure. Purification by flash column chromatography provided NH-sulfoximine 4.
• 21 For HPLC analytical data, see the Supporting Information.
• 22 For a recent illustrative example, see: Frings M, Thomé I, Schiffers I, Pan FF, Bolm C. Chem. Eur. J. 2014; 20: 1691
• 23a Sedelmeier J, Bolm C. J. Org. Chem. 2005; 70: 6904
• 23b For a recent observation, see: Frings M, Atodiresei I, Bolm C. Molbank 2014; M834
• 24 Schmidbaur H, Kammel G. Chem. Ber. 1971; 104: 3234
• 25 For a recent study on sulfoximine N-alkylations under strongly basic conditions (with KOH in DMSO), see: Hendriks CM. M, Bohmann RA, Bohlem M, Bolm C. Adv. Synth. Catal. 2014; 356: 1847
• 26 Meanwell NA. J. Med. Chem. 2011; 54: 2529
• 27 For early examples, see: García Mancheño O, Bolm C. Org. Lett. 2007; 9: 2951